This chemical is primarily used in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of drugs targeting neurological disorders, such as epilepsy and anxiety, due to its structural compatibility with biologically active molecules. Its tert-butoxycarbonyl (Boc) protecting group allows for selective reactions during peptide synthesis, making it valuable in the creation of complex organic molecules. Additionally, it is utilized in research settings for the study of enzyme inhibition and receptor binding, aiding in the discovery of new therapeutic agents. Its dichlorophenyl moiety contributes to its potential use in the design of compounds with enhanced biological activity and specificity.